JP:190A Stock Latest News
Company AnnouncementsChordia Therapeutics Moves to Clean Up Deficit Through Capital Reserve Reclassification1w ago190A
Company AnnouncementsChordia Therapeutics Maps Out FY2026 Results and FY2027 Priorities2w ago190A
Company AnnouncementsChordia Therapeutics Narrows Annual Loss but Maintains Cautious Outlook2w ago190A
Company AnnouncementsChordia Therapeutics Secures AMED Grant to Accelerate Global Development of Rogocekib1M ago190A
Company AnnouncementsChordia Therapeutics Completes Initial Expansion Cohort Enrollment for Rogocekib Trial1M ago190A
Company AnnouncementsChordia Wins Japan Orphan Drug Status for Lead AML Therapy rogocekib2M ago190ACompany AnnouncementsChordia’s Lead Cancer Drug Rogocekib Wins Japan Orphan Drug Endorsement for AML3M ago190A
Company AnnouncementsChordia Therapeutics Wins AMED Grant for Advanced Cancer Research with Kyoto University3M ago190A
Company AnnouncementsChordia Therapeutics Narrows Nine-Month Loss But Stays Deep in Red3M ago190A
Company AnnouncementsChordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update6M ago190A
Company AnnouncementsChordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast6M ago190A
Company AnnouncementsChordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort7M ago190A
Company AnnouncementsChordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts8M ago190A
Company AnnouncementsChordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises9M ago190A
Company AnnouncementsChordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink9M ago190A
Company AnnouncementsChordia Therapeutics to Record Grant Income in Fiscal Year 202611M ago190A
Company AnnouncementsChordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment1y ago190A
Company AnnouncementsChordia Therapeutics Restructures Capital to Strengthen Financial Foundation1y ago190A
Company AnnouncementsChordia Therapeutics Reports Fiscal Year 2025 Financial Results1y ago190ACompany AnnouncementsChordia Therapeutics Reports Continued Losses in Latest Financial Results1y ago190A
